Behavioral Neuroscience – News and Features

In a new paper, researchers describe the creation of synthetic peptides, a class of antibiotics, derived from the secretions of a frog commonly found in South Asia.

A study from Geneva University Hospitals and the University of Geneva found that adults with ADHD have increased brain iron levels and higher neurofilament light chain protein (NfL) in their blood, markers associated with dementia.

Around 50–90% of brain tumor patients that survive at least 6 months after radiotherapy experience some form of cognitive decline, such as memory loss. In a systematic review, we examined damage to the normal brain tissue after brain irradiation.

New research reveals that stimulating angiotensin type 2 receptor (AT2R) neurons in the central nucleus of the amygdala can lower blood pressure and reduce anxiety in mice.

A comprehensive study from Karolinska Institutet shows that people with fatty liver disease have almost twice the mortality rate of the general population.

The Galápagos yellow warblers living in roadside territories showed increased aggression.

A recent trial on gantenerumab showed that the drug could reduce the risk of Alzheimer’s symptoms by 50% in pre-symptomatic individuals with inherited risk. However, safety concerns remain.

A recent study challenges the effectiveness of microdosing LSD for treating ADHD. Despite self-reported improvements, the clinical trial found no significant difference between low-dose LSD and placebo in reducing ADHD symptoms.

Researchers at Washington University found that stimulating meningeal lymphatic vessels in aged mice improved memory performance. The study highlights the potential of enhancing waste clearance to reduce inflammation and improve cognitive function.

A study from the University of the Basque Country explores blood-based biomarkers to understand why some cannabis users develop schizophrenia. Using lipidomics, researchers identified specific fatty acid profiles that differentiated users.